1. Home
  2. ITRM vs GSIW Comparison

ITRM vs GSIW Comparison

Compare ITRM & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.17

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

GSIW

Garden Stage Limited

N/A

Current Price

$18.07

Market Cap

28.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRM
GSIW
Founded
2015
2016
Country
Ireland
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
28.6M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
ITRM
GSIW
Price
$0.17
$18.07
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.1M
569.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$947.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.05
52 Week High
$1.49
$36.90

Technical Indicators

Market Signals
Indicator
ITRM
GSIW
Relative Strength Index (RSI) 36.94 65.68
Support Level $0.14 $0.11
Resistance Level $0.39 $36.90
Average True Range (ATR) 0.02 3.82
MACD 0.00 1.35
Stochastic Oscillator 21.36 50.18

Price Performance

Historical Comparison
ITRM
GSIW

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: